FGL1 is primarily associated with liver regeneration, non-alcoholic fatty liver disease (NAFLD), and liver cancer, while FGL2 is known to be involved in viral hepatitis, liver fibrosis, HCC, and liver transplantation. This evidence concerns the gene FGL2 and metabolic dysfunction-associated steatotic liver disease.